Anna Zmelonek-Znamirowska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anna Zmelonek-Znamirowska has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Grzegorz Świercz
Collegium Medicum, Jan Kochanowski University in Kielce, 25-369 Kielce, Poland
8 shared publications - Jakub Mlodawski
Collegium Medicum, Jan Kochanowski University, 25-369 Kielce, Poland
8 shared publications - Marta Mlodawska
Collegium Medicum, Jan Kochanowski University, 25-369 Kielce, Poland
8 shared publications - Lukasz Pawlik
Department of Information Systems, Kielce University of Technology, 25-314 Kielce, Poland
3 shared publications - Daniel Wolder
Department of Obstetrics and Gynecology, Collegium Medicum, Jan Kochanowski University of Kielce, Kielce, Poland
2 shared publications - Karolina Detka
Clinic of Obstetrics and Gynecology, Provincial Combined Hospital in Kielce, 25-736 Kielce, Poland
2 shared publications
Latest Publications
- Open Access
- 15 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (22) , 8946
Predictors of Missing Outputs in AI-Based Fetal CNS Biometry Using SonoCNS: A Real-World Cohort Study
Background: Artificial intelligence (AI)-based automated fetal central nervous system (CNS) biometry using SonoCNS may streamline ultrasound assessment, but missing outputs occur in clinical practice. This study aimed to quantify the frequency and patterns of missing SonoCNS measurements across two separately acquired fetal head volumes and to investigate their associations with gestational age, operator, fetal presentation, and fetal biometric characteristics. Methods: This single-center retrospective secondary analysis used prospectively collected data from 385 women examined between 1 May 2022 and 31 May 2023. Each participant underwent second- or third-trimester ultrasound assessment with SonoCNS measurements obtained from two separately acquired volumes (a1, a2) for BPD, HC, OFD, cisterna magna (CM), lateral ventricular atrial width (Vp), and transverse cerebellar diameter (Cereb). Primary endpoints (full set: BPD/HC/OFD/CM/Vp/Cereb) were persistent AI failure (the same parameter missing in both acquisitions for at least one of the six parameters) and AI instability (missing ≥1 parameter in ≥1 acquisition). Structure-specific models assessed miss_CM, miss_Vp, and miss_Cereb. Logistic regression adjusted for operator, fetal presentation, gravidity/parity, and GA-adjusted fetal size residual z-scores (EFW-, HC-, and BPD-for-GA); sensitivity analyses were restricted to AZZ and to examinations at p < 0.001). In multivariable models, the corresponding adjusted ORs were 9.61 (95% CI 4.55–20.28), 9.62 (4.57–20.27), and 21.29 (10.25–44.22), respectively (all p < 0.001). These associations persisted in AZZ-only analyses. Examinations performed by JM were associated with lower CM/Cereb instability and persistent failure, although operator comparisons were limited by the absence of JM examinations at ≥28 weeks. Conclusions: Missing SonoCNS outputs were common across two acquisitions. Later gestational age was associated with greater output instability, particularly for lateral ventricular atrial width, but not with persistent failure after adjustment. Operator-associated differences were observed for selected endpoints; however, their interpretation is limited by the unequal gestational age distribution and the absence of objective acquisition-quality assessment.
- 15 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (22) , 8946
Open AccessPredictors of Missing Outputs in AI-Based Fetal CNS Biometry Using SonoCNS: A Real-World Cohort Study
Background: Artificial intelligence (AI)-based automated fetal central nervous system (CNS) biometry using SonoCNS may streamline ultrasound assessment, but missing outputs occur in clinical practice. This study aimed to quantify the frequency and patterns of missing SonoCNS measurements across two separately acquired fetal head volumes and to investigate their associations with gestational age, operator, fetal presentation, and fetal biometric characteristics. Methods: This single-center retrospective secondary analysis used prospectively collected data from 385 women examined between 1 May 2022 and 31 May 2023. Each participant underwent second- or third-trimester ultrasound assessment with SonoCNS measurements obtained from two separately acquired volumes (a1, a2) for BPD, HC, OFD, cisterna magna (CM), lateral ventricular atrial width (Vp), and transverse cerebellar diameter (Cereb). Primary endpoints (full set: BPD/HC/OFD/CM/Vp/Cereb) were persistent AI failure (the same parameter missing in both acquisitions for at least one of the six parameters) and AI instability (missing ≥1 parameter in ≥1 acquisition). Structure-specific models assessed miss_CM, miss_Vp, and miss_Cereb. Logistic regression adjusted for operator, fetal presentation, gravidity/parity, and GA-adjusted fetal size residual z-scores (EFW-, HC-, and BPD-for-GA); sensitivity analyses were restricted to AZZ and to examinations at p < 0.001). In multivariable models, the corresponding adjusted ORs were 9.61 (95% CI 4.55–20.28), 9.62 (4.57–20.27), and 21.29 (10.25–44.22), respectively (all p < 0.001). These associations persisted in AZZ-only analyses. Examinations performed by JM were associated with lower CM/Cereb instability and persistent failure, although operator comparisons were limited by the absence of JM examinations at ≥28 weeks. Conclusions: Missing SonoCNS outputs were common across two acquisitions. Later gestational age was associated with greater output instability, particularly for lateral ventricular atrial width, but not with persistent failure after adjustment. Operator-associated differences were observed for selected endpoints; however, their interpretation is limited by the unequal gestational age distribution and the absence of objective acquisition-quality assessment.
- Open Access
- 19 October 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (10) , 2392
Decision Limits for Fetal Speckle-Tracking Outputs: Minimal Detectable Change and Threshold Instability in FetalHQ
Background: Fetal Heart Quantification (FetalHQ) enables detailed assessment of fetal cardiac morphology and function using two-dimensional speckle-tracking echocardiography. However, previous studies have focused primarily on conventional reproducibility metrics such as the intraclass correlation coefficient (ICC). From a clinical perspective, it is more relevant to determine what magnitude of change exceeds measurement noise and whether a single result may lead to unstable classification relative to normative thresholds. The aim of this study was to evaluate the decision limits of selected FetalHQ parameters, including the minimal detectable change (MDC95), threshold instability, and the theoretical effect of averaging two independent analyses. Materials and Methods: This methodological study included 93 paired analyses (_1 and _2) obtained from the same recorded four-chamber cine loop under the assumption of zero biological variability. The intra-operator subset (n = 34) and inter-operator subset (n = 59) were analyzed separately. For key parameters, we determined the proportion of usable pairs after quality filtering, bias, Bland–Altman 95% limits of agreement, MDC95, classification flip rates for normalized outputs, and the width of the uncertainty zone (grey zone) around diagnostic thresholds. In addition, we estimated the effect of a mean-of-two workflow on measurement error reduction. Results: The best analytical performance was observed for left ventricular volumetric parameters, particularly LV EDV and LV ESV, which showed the highest proportion of usable pairs (88.2–94.9%) and relatively low MDC95 values. Functional and deformation metrics performed substantially worse, including LV EF, LV FRAC, LV GLS, and RV TAPSE, all of which were characterized by lower usability and wider limits of agreement, especially in the inter-operator analysis. Classification instability was greatest for normalized parameters. In the inter-operator analysis, classification flips occurred in 33.3% of cases for LV EF centile 2. Under the theoretical assumption of independent random measurement error, the estimated MDC95 for the mean of two analyses was approximately 29% lower than that for a single analysis; this reduction was mathematically derived rather than prospectively observed. Conclusions: FetalHQ showed the highest analytical stability for simpler LV volumetric parameters, whereas functional and deformation outputs remained substantially more susceptible to measurement noise and classification instability, particularly between operators. In practice, this means that a single measurement obtained near normative thresholds may be insufficient for reliable interpretation. A theoretical mean-of-two approach may reduce random measurement uncertainty, but this strategy was not prospectively validated and does not overcome the limitations of the least analytically stable parameters.
- 19 October 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (10) , 2392
Open AccessDecision Limits for Fetal Speckle-Tracking Outputs: Minimal Detectable Change and Threshold Instability in FetalHQ
Background: Fetal Heart Quantification (FetalHQ) enables detailed assessment of fetal cardiac morphology and function using two-dimensional speckle-tracking echocardiography. However, previous studies have focused primarily on conventional reproducibility metrics such as the intraclass correlation coefficient (ICC). From a clinical perspective, it is more relevant to determine what magnitude of change exceeds measurement noise and whether a single result may lead to unstable classification relative to normative thresholds. The aim of this study was to evaluate the decision limits of selected FetalHQ parameters, including the minimal detectable change (MDC95), threshold instability, and the theoretical effect of averaging two independent analyses. Materials and Methods: This methodological study included 93 paired analyses (_1 and _2) obtained from the same recorded four-chamber cine loop under the assumption of zero biological variability. The intra-operator subset (n = 34) and inter-operator subset (n = 59) were analyzed separately. For key parameters, we determined the proportion of usable pairs after quality filtering, bias, Bland–Altman 95% limits of agreement, MDC95, classification flip rates for normalized outputs, and the width of the uncertainty zone (grey zone) around diagnostic thresholds. In addition, we estimated the effect of a mean-of-two workflow on measurement error reduction. Results: The best analytical performance was observed for left ventricular volumetric parameters, particularly LV EDV and LV ESV, which showed the highest proportion of usable pairs (88.2–94.9%) and relatively low MDC95 values. Functional and deformation metrics performed substantially worse, including LV EF, LV FRAC, LV GLS, and RV TAPSE, all of which were characterized by lower usability and wider limits of agreement, especially in the inter-operator analysis. Classification instability was greatest for normalized parameters. In the inter-operator analysis, classification flips occurred in 33.3% of cases for LV EF centile 2. Under the theoretical assumption of independent random measurement error, the estimated MDC95 for the mean of two analyses was approximately 29% lower than that for a single analysis; this reduction was mathematically derived rather than prospectively observed. Conclusions: FetalHQ showed the highest analytical stability for simpler LV volumetric parameters, whereas functional and deformation outputs remained substantially more susceptible to measurement noise and classification instability, particularly between operators. In practice, this means that a single measurement obtained near normative thresholds may be insufficient for reliable interpretation. A theoretical mean-of-two approach may reduce random measurement uncertainty, but this strategy was not prospectively validated and does not overcome the limitations of the least analytically stable parameters.
- Open Access
Empirical Antibiotic Initiation for Suspected Early-Onset Neonatal Infection in the Setting of Maternal GBS Screening and Intrapartum Antibiotic Prophylaxis: A Single-Center Retrospective Cohort Study
Background and Objectives: Maternal Group B Streptococcus (GBS) screening and intrapartum antibiotic prophylaxis have reduced early-onset GBS disease. However, suspected early-onset neonatal infection (EONI) remains a broader clinical challenge, as signs prompting empirical antibiotic treatment may also occur in non-infectious disorders of postnatal adaptation. Therefore, this study evaluated the frequency of systemic antibiotic initiation for suspected EONI and the utilization and microbiological yield of blood cultures in a single-center cohort managed with routine maternal GBS screening and intrapartum antibiotic prophylaxis. Materials and Methods: This retrospective cohort study included 2010 mother–newborn dyads delivered between 2019 and 2022. The primary outcome was systemic antibiotic therapy initiated within the first 72 h of life because of suspected EONI. Blood culture utilization and microbiological yield were analyzed separately from the primary treatment outcome. Positive blood culture findings were interpreted descriptively because of the small number of isolates and the possibility of contamination. Results: Empirical systemic antibiotic therapy for suspected EONI was initiated in 71 neonates (3.53%). The observed treatment rates among neonates born to GBS-colonized and non-colonized mothers were 16/402 (3.98%) vs. 55/1608 (3.42%) (RR 1.16, 95% CI 0.67–2.01; p = 0.59). In an exploratory multivariable analysis, the adjusted OR for maternal GBS colonization and antibiotic initiation was 1.33 (95% CI 0.68–2.60; p = 0.408). Lower gestational age was the strongest associated factor. Treated neonates were more frequently preterm and had more respiratory disorders, NICU admissions, pPROM, and lower Apgar scores. Blood cultures were obtained in 79 neonates, including 63 treated for suspected EONI. Nine sampled neonates had positive blood cultures, including seven treated neonates; several isolates were compatible with contamination. No GBS isolates were detected among the sampled neonates. Conclusions: Empirical systemic antibiotics were initiated for suspected EONI in 3.53% of neonates. This treatment frequency does not estimate early-onset sepsis (EOS) incidence. The study did not detect a statistically significant association between maternal GBS colonization and antibiotic initiation, but the wide confidence intervals do not exclude clinically relevant increases in treatment. Selective blood culture sampling, possible contamination, and incomplete microbiological adjudication preclude reliable estimates of culture-confirmed EOS incidence or pathogen distribution.
Open AccessEmpirical Antibiotic Initiation for Suspected Early-Onset Neonatal Infection in the Setting of Maternal GBS Screening and Intrapartum Antibiotic Prophylaxis: A Single-Center Retrospective Cohort Study
Background and Objectives: Maternal Group B Streptococcus (GBS) screening and intrapartum antibiotic prophylaxis have reduced early-onset GBS disease. However, suspected early-onset neonatal infection (EONI) remains a broader clinical challenge, as signs prompting empirical antibiotic treatment may also occur in non-infectious disorders of postnatal adaptation. Therefore, this study evaluated the frequency of systemic antibiotic initiation for suspected EONI and the utilization and microbiological yield of blood cultures in a single-center cohort managed with routine maternal GBS screening and intrapartum antibiotic prophylaxis. Materials and Methods: This retrospective cohort study included 2010 mother–newborn dyads delivered between 2019 and 2022. The primary outcome was systemic antibiotic therapy initiated within the first 72 h of life because of suspected EONI. Blood culture utilization and microbiological yield were analyzed separately from the primary treatment outcome. Positive blood culture findings were interpreted descriptively because of the small number of isolates and the possibility of contamination. Results: Empirical systemic antibiotic therapy for suspected EONI was initiated in 71 neonates (3.53%). The observed treatment rates among neonates born to GBS-colonized and non-colonized mothers were 16/402 (3.98%) vs. 55/1608 (3.42%) (RR 1.16, 95% CI 0.67–2.01; p = 0.59). In an exploratory multivariable analysis, the adjusted OR for maternal GBS colonization and antibiotic initiation was 1.33 (95% CI 0.68–2.60; p = 0.408). Lower gestational age was the strongest associated factor. Treated neonates were more frequently preterm and had more respiratory disorders, NICU admissions, pPROM, and lower Apgar scores. Blood cultures were obtained in 79 neonates, including 63 treated for suspected EONI. Nine sampled neonates had positive blood cultures, including seven treated neonates; several isolates were compatible with contamination. No GBS isolates were detected among the sampled neonates. Conclusions: Empirical systemic antibiotics were initiated for suspected EONI in 3.53% of neonates. This treatment frequency does not estimate early-onset sepsis (EOS) incidence. The study did not detect a statistically significant association between maternal GBS colonization and antibiotic initiation, but the wide confidence intervals do not exclude clinically relevant increases in treatment. Selective blood culture sampling, possible contamination, and incomplete microbiological adjudication preclude reliable estimates of culture-confirmed EOS incidence or pathogen distribution.
- Top Cited PapersOpen Access
- 28 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (15) , 5891
Neonatal Respiratory Outcomes in Placenta Previa with Histopathologically Confirmed Placenta Accreta Spectrum
Background and Objectives: Placenta accreta spectrum (PAS) complicating placenta praevia is associated with increased maternal morbidity; however, neonatal respiratory burden may be underappreciated. We compared neonatal outcomes between pregnancies complicated by placenta praevia with and without histopathologically confirmed PAS, with additional adjustment of respiratory outcomes for gestational age at delivery. Materials and Methods: We conducted a retrospective single-centre cohort study (n = 82). Based on placental histopathology, women were classified as PAS (n = 37; accreta/increta/percreta) or non-PAS (n = 45). Respiratory endpoints included respiratory resuscitation at birth, non-invasive respiratory support, and supplemental oxygen requirement with fraction of inspired oxygen (FiO2) > 0.21 during neonatal intensive care unit (NICU) hospitalization. Logistic regression models adjusted respiratory endpoints for gestational age. Results: Data were available for 80/82 neonates. Compared with non-PAS, PAS cases had higher rates of respiratory resuscitation at birth (26/36 [72.2%] vs. 19/44 [43.2%], p = 0.013), non-invasive respiratory support (31/36 [86.1%] vs. 24/44 [54.5%], p = 0.003), and supplemental oxygen requirement (29/36 [80.6%] vs. 21/44 [47.7%], p = 0.003). After adjustment for gestational age, PAS remained associated with respiratory resuscitation (adjusted odds ratio [aOR] 3.34, 95% confidence interval [CI] 1.21–9.27; p = 0.020) and supplemental oxygen requirement (aOR 4.60, 95% CI 1.35–15.75; p = 0.015). The association with non-invasive respiratory support did not reach statistical significance (aOR 4.46, 95% CI 0.92–21.68; p = 0.064). Conclusions: Histopathologically confirmed PAS was associated with higher neonatal respiratory support requirements after adjustment for gestational age, supporting anticipatory obstetric–neonatal planning when PAS is suspected.
- 28 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (15) , 5891
Top Cited PapersOpen AccessNeonatal Respiratory Outcomes in Placenta Previa with Histopathologically Confirmed Placenta Accreta Spectrum
Background and Objectives: Placenta accreta spectrum (PAS) complicating placenta praevia is associated with increased maternal morbidity; however, neonatal respiratory burden may be underappreciated. We compared neonatal outcomes between pregnancies complicated by placenta praevia with and without histopathologically confirmed PAS, with additional adjustment of respiratory outcomes for gestational age at delivery. Materials and Methods: We conducted a retrospective single-centre cohort study (n = 82). Based on placental histopathology, women were classified as PAS (n = 37; accreta/increta/percreta) or non-PAS (n = 45). Respiratory endpoints included respiratory resuscitation at birth, non-invasive respiratory support, and supplemental oxygen requirement with fraction of inspired oxygen (FiO2) > 0.21 during neonatal intensive care unit (NICU) hospitalization. Logistic regression models adjusted respiratory endpoints for gestational age. Results: Data were available for 80/82 neonates. Compared with non-PAS, PAS cases had higher rates of respiratory resuscitation at birth (26/36 [72.2%] vs. 19/44 [43.2%], p = 0.013), non-invasive respiratory support (31/36 [86.1%] vs. 24/44 [54.5%], p = 0.003), and supplemental oxygen requirement (29/36 [80.6%] vs. 21/44 [47.7%], p = 0.003). After adjustment for gestational age, PAS remained associated with respiratory resuscitation (adjusted odds ratio [aOR] 3.34, 95% confidence interval [CI] 1.21–9.27; p = 0.020) and supplemental oxygen requirement (aOR 4.60, 95% CI 1.35–15.75; p = 0.015). The association with non-invasive respiratory support did not reach statistical significance (aOR 4.46, 95% CI 0.92–21.68; p = 0.064). Conclusions: Histopathologically confirmed PAS was associated with higher neonatal respiratory support requirements after adjustment for gestational age, supporting anticipatory obstetric–neonatal planning when PAS is suspected.
- Open Access
- 24 March 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (7) , 2469
Reply to DeVore, G.R. Determination of the Same Cardiac Cycle When Analyzing Cine Clips for Use by FetalHQ to Assess Intraobserver and Interobserver Variability. Comment on “Mlodawski et al. Reproducibility Challenges in Fetal Cardiac Function Analysis with 2D Speckle-Tracking Echocardiography: Insights from FetalHQ. J. Clin. Med. 2025, 14, 3301”
- 24 March 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (7) , 2469
Open AccessReply to DeVore, G.R. Determination of the Same Cardiac Cycle When Analyzing Cine Clips for Use by FetalHQ to Assess Intraobserver and Interobserver Variability. Comment on “Mlodawski et al. Reproducibility Challenges in Fetal Cardiac Function Analysis with 2D Speckle-Tracking Echocardiography: Insights from FetalHQ. J. Clin. Med. 2025, 14, 3301”
- Open Access
- 15 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (4) , 1536
From Childhood to Old Age: Current Knowledge and Practical Approaches to Metabolic Dysfunction-Associated Steatotic Liver Disease
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is one of the most common chronic liver diseases across all age groups. Methods: This review synthesizes the current evidence from landmark studies on the risk factors, diagnosis, and management of MASLD in pediatric, adult, and particularly elderly patients. Results: Based on the current data, we demonstrated that the prevalence of MASLD increases with age from childhood to middle adulthood, whereas, in elderly individuals, there is no further age-related increase observed. In the pathogenesis of the disease, familial and prenatal factors predominate in the youngest patients, while metabolic factors are the main contributors in adults. However, obesity remains the most significant risk factor for MASLD across all age groups. Therefore, systematic screening for MASLD should be strongly recommended in individuals with obesity. Laboratory parameters indicating an increased risk of MASLD are primarily recommended in screening regimens for children and adults; however, in elderly patients, these parameters may remain within normal ranges due to the long-standing disease course and progression toward fibrosis. On the basis of current studies and guidelines, we showed that lifestyle modification, including dietary changes and increased physical activity, is the cornerstone of treatment across all age groups. Nevertheless, non-pharmacological interventions have limitations in pediatric and elderly populations and are implemented less effectively in these groups than in middle-aged patients. Conclusions: The early identification of high-risk patients and implementation of multidisciplinary, age-targeted metabolic prevention strategies are essential to prevent MASLD progression and its non-liver complications.
- 15 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (4) , 1536
Open AccessFrom Childhood to Old Age: Current Knowledge and Practical Approaches to Metabolic Dysfunction-Associated Steatotic Liver Disease
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is one of the most common chronic liver diseases across all age groups. Methods: This review synthesizes the current evidence from landmark studies on the risk factors, diagnosis, and management of MASLD in pediatric, adult, and particularly elderly patients. Results: Based on the current data, we demonstrated that the prevalence of MASLD increases with age from childhood to middle adulthood, whereas, in elderly individuals, there is no further age-related increase observed. In the pathogenesis of the disease, familial and prenatal factors predominate in the youngest patients, while metabolic factors are the main contributors in adults. However, obesity remains the most significant risk factor for MASLD across all age groups. Therefore, systematic screening for MASLD should be strongly recommended in individuals with obesity. Laboratory parameters indicating an increased risk of MASLD are primarily recommended in screening regimens for children and adults; however, in elderly patients, these parameters may remain within normal ranges due to the long-standing disease course and progression toward fibrosis. On the basis of current studies and guidelines, we showed that lifestyle modification, including dietary changes and increased physical activity, is the cornerstone of treatment across all age groups. Nevertheless, non-pharmacological interventions have limitations in pediatric and elderly populations and are implemented less effectively in these groups than in middle-aged patients. Conclusions: The early identification of high-risk patients and implementation of multidisciplinary, age-targeted metabolic prevention strategies are essential to prevent MASLD progression and its non-liver complications.
- Open Access
- 30 September 2025
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 26, e948218
Disseminated Peritoneal Leiomyomatosis of the Peritoneum Following Laparoscopic Supracervical Hysterectomy with Morcellation: A Case Report
BACKGROUND Disseminated peritoneal leiomyomatosis is a rare complication of laparoscopic procedures involving uterine morcellation. These fibroid-like lesions, which derive their blood supply from non-uterine sources, may develop after myomectomy, supracervical hysterectomy, or total laparoscopic hysterectomy - particularly when mechanical morcellation is used. Although the incidence is low, disseminated leiomyomatosis should be considered in the differential diagnosis of abdominal or pelvic pain in patients with a history of such surgeries. CASE REPORT A 40-year-old woman presented with intermittent lower abdominal pain. She had undergone a laparoscopic supracervical hysterectomy with salpingectomy 5 years earlier due to abnormal uterine bleeding, during which uncontained mechanical morcellation was performed. At present, transvaginal ultrasound revealed a solid mass adjacent to the bladder with features suggestive of a leiomyoma. Magnetic resonance imaging (MRI) showed multiple lesions, including a polycyclic mass located above the bladder and additional foci near the sigmoid colon and the bladder dome. Laparoscopy confirmed the presence of leiomyomas on the anterior abdominal wall, sigmoid colon adventitia, and bladder dome. All lesions were excised using laparoscopic techniques, and the postoperative course was uneventful. Histopathological examination confirmed leiomyomas with positive estrogen and progesterone receptor expression. CONCLUSIONS This case underscores the importance of considering disseminated peritoneal leiomyomatosis in the differential diagnosis of abdominal or pelvic pain in patients with a history of laparoscopic hysterectomy with morcellation. It also emphasizes that this condition can mimic malignancy on imaging studies and highlights the essential role of histopathological examination in diagnosing this benign disease.
- 30 September 2025
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 26, e948218
Open AccessDisseminated Peritoneal Leiomyomatosis of the Peritoneum Following Laparoscopic Supracervical Hysterectomy with Morcellation: A Case Report
BACKGROUND Disseminated peritoneal leiomyomatosis is a rare complication of laparoscopic procedures involving uterine morcellation. These fibroid-like lesions, which derive their blood supply from non-uterine sources, may develop after myomectomy, supracervical hysterectomy, or total laparoscopic hysterectomy - particularly when mechanical morcellation is used. Although the incidence is low, disseminated leiomyomatosis should be considered in the differential diagnosis of abdominal or pelvic pain in patients with a history of such surgeries. CASE REPORT A 40-year-old woman presented with intermittent lower abdominal pain. She had undergone a laparoscopic supracervical hysterectomy with salpingectomy 5 years earlier due to abnormal uterine bleeding, during which uncontained mechanical morcellation was performed. At present, transvaginal ultrasound revealed a solid mass adjacent to the bladder with features suggestive of a leiomyoma. Magnetic resonance imaging (MRI) showed multiple lesions, including a polycyclic mass located above the bladder and additional foci near the sigmoid colon and the bladder dome. Laparoscopy confirmed the presence of leiomyomas on the anterior abdominal wall, sigmoid colon adventitia, and bladder dome. All lesions were excised using laparoscopic techniques, and the postoperative course was uneventful. Histopathological examination confirmed leiomyomas with positive estrogen and progesterone receptor expression. CONCLUSIONS This case underscores the importance of considering disseminated peritoneal leiomyomatosis in the differential diagnosis of abdominal or pelvic pain in patients with a history of laparoscopic hysterectomy with morcellation. It also emphasizes that this condition can mimic malignancy on imaging studies and highlights the essential role of histopathological examination in diagnosing this benign disease.
- Open Access
- 9 May 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (10) , 3301
Reproducibility Challenges in Fetal Cardiac Function Analysis with 2D Speckle-Tracking Echocardiography: Insights from FetalHQ
Background/Objectives: Functional assessment of the fetal heart remains a significant challenge in contemporary perinatology due to the absence of a universally accepted gold standard for such evaluations. The aim of this study was to evaluate the reproducibility of parameters derived from two-dimensional speckle-tracking echocardiography (2D STE) using the FetalHQ software. Methods: We enrolled 87 pregnant women between 19 and 23 weeks of gestation who were undergoing mid-trimester screening at the Provincial Hospital Complex in Kielce. Two independent operators acquired 5 s cine-loops of four-chamber views (4CVs) according to a standardized protocol. Reproducibility was assessed by examining intra- and interobserver variability using the intraclass correlation coefficient (ICC) for several cardiac parameters, including the global sphericity index (GSI), global longitudinal strain (GLS), stroke volume (SV), and fractional area change (FAC). Results: Reproducibility varied substantially across the assessed parameters. The highest intraobserver reproducibility was observed for the 4CV GSI (ICC > 0.9). Moderate intraobserver reproducibility (ICCs ranging from 0.5 to 0.75) was noted for left ventricular (LV) parameters, such as end-diastolic area, end-systolic area, end-diastolic volume, and end-systolic volume. Interobserver variability demonstrated higher ICC values, with excellent reproducibility (ICC > 0.9) for the 4CV GSI and LV volume measurements. Good reproducibility (ICCs between 0.75 and 0.9) was observed for specific left ventricular segmental strain indices, whereas other parameters showed moderate to poor reproducibility (ICC < 0.5). Conclusions: Two-dimensional speckle-tracking echocardiography (2D STE) using FetalHQ exhibits variable reproducibility, which is influenced by the choice of parameters, operator experience, and technical factors. This method holds potential for fetal cardiac assessment; however, additional research is required to improve its predictive accuracy and streamline the evaluation process for routine clinical application.
- 9 May 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (10) , 3301
Open AccessReproducibility Challenges in Fetal Cardiac Function Analysis with 2D Speckle-Tracking Echocardiography: Insights from FetalHQ
Background/Objectives: Functional assessment of the fetal heart remains a significant challenge in contemporary perinatology due to the absence of a universally accepted gold standard for such evaluations. The aim of this study was to evaluate the reproducibility of parameters derived from two-dimensional speckle-tracking echocardiography (2D STE) using the FetalHQ software. Methods: We enrolled 87 pregnant women between 19 and 23 weeks of gestation who were undergoing mid-trimester screening at the Provincial Hospital Complex in Kielce. Two independent operators acquired 5 s cine-loops of four-chamber views (4CVs) according to a standardized protocol. Reproducibility was assessed by examining intra- and interobserver variability using the intraclass correlation coefficient (ICC) for several cardiac parameters, including the global sphericity index (GSI), global longitudinal strain (GLS), stroke volume (SV), and fractional area change (FAC). Results: Reproducibility varied substantially across the assessed parameters. The highest intraobserver reproducibility was observed for the 4CV GSI (ICC > 0.9). Moderate intraobserver reproducibility (ICCs ranging from 0.5 to 0.75) was noted for left ventricular (LV) parameters, such as end-diastolic area, end-systolic area, end-diastolic volume, and end-systolic volume. Interobserver variability demonstrated higher ICC values, with excellent reproducibility (ICC > 0.9) for the 4CV GSI and LV volume measurements. Good reproducibility (ICCs between 0.75 and 0.9) was observed for specific left ventricular segmental strain indices, whereas other parameters showed moderate to poor reproducibility (ICC < 0.5). Conclusions: Two-dimensional speckle-tracking echocardiography (2D STE) using FetalHQ exhibits variable reproducibility, which is influenced by the choice of parameters, operator experience, and technical factors. This method holds potential for fetal cardiac assessment; however, additional research is required to improve its predictive accuracy and streamline the evaluation process for routine clinical application.
- Open Access
- 29 March 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (7) , 1982
Navigating Uncertain Waters: First-Trimester Screening’s Role in Identifying Neonatal Complications
Background: Contemporary diagnostic methods aimed at assessing neonatal outcomes predominantly rely on the medical history of pregnant women. Ideally, universal biomarkers indicating an increased risk of delivering infants in poor clinical condition, with a heightened likelihood of requiring hospitalization in a Neonatal Intensive Care Unit (NICU), would be beneficial for appropriately stratifying pregnant women into a high-risk category. Our study evaluated whether biochemical and ultrasonographical markers universally used in first-trimester screenings for non-heritable chromosomal aberrations could serve this purpose. Methods: This study encompassed 1164 patients who underwent first-trimester screening, including patient history, ultrasound examinations, and biochemical tests for pregnancy-associated plasma protein-A (PAPP-A) and the free beta-HCG subunit (fbHCG), from January 2019 to December 2021. The research concentrated on the correlation between these prenatal test results and neonatal outcomes, particularly Apgar scores, umbilical blood pH levels, and the necessity for NICU admission. Results: In our cohort, neonates scoring lower than 8 on the Apgar scale at birth exhibited lower concentrations of PAPP-A in the first trimester, both in raw and normalized values (PAPP-A MoM 0.93 vs. 1.027, p = 0.032). We also observed a higher pulsatility index in the venous duct in the first trimester in full-term neonates born with p = 0.04). We also noted that neonates requiring NICU hospitalization post-delivery had lower first-trimester bHCG concentrations (0.93 MoM vs. 1.11 MoM, p = 0.03). However, none of the correlations in our study translated into a robust prognostic ability for predicting dichotomous outcomes. All areas under the curve achieved a value < 0.7. Conclusions: Low concentrations of PAPP-A and free bHCG subunit in the first trimester may be associated with poorer clinical and biochemical conditions in neonates post-delivery. However, the relationship is weak and has limited predictive capability. Further research evaluating these relationships is necessary for the appropriate stratification of pregnant women into high-risk categories for neonatological complications.
- 29 March 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (7) , 1982
Open AccessNavigating Uncertain Waters: First-Trimester Screening’s Role in Identifying Neonatal Complications
Background: Contemporary diagnostic methods aimed at assessing neonatal outcomes predominantly rely on the medical history of pregnant women. Ideally, universal biomarkers indicating an increased risk of delivering infants in poor clinical condition, with a heightened likelihood of requiring hospitalization in a Neonatal Intensive Care Unit (NICU), would be beneficial for appropriately stratifying pregnant women into a high-risk category. Our study evaluated whether biochemical and ultrasonographical markers universally used in first-trimester screenings for non-heritable chromosomal aberrations could serve this purpose. Methods: This study encompassed 1164 patients who underwent first-trimester screening, including patient history, ultrasound examinations, and biochemical tests for pregnancy-associated plasma protein-A (PAPP-A) and the free beta-HCG subunit (fbHCG), from January 2019 to December 2021. The research concentrated on the correlation between these prenatal test results and neonatal outcomes, particularly Apgar scores, umbilical blood pH levels, and the necessity for NICU admission. Results: In our cohort, neonates scoring lower than 8 on the Apgar scale at birth exhibited lower concentrations of PAPP-A in the first trimester, both in raw and normalized values (PAPP-A MoM 0.93 vs. 1.027, p = 0.032). We also observed a higher pulsatility index in the venous duct in the first trimester in full-term neonates born with p = 0.04). We also noted that neonates requiring NICU hospitalization post-delivery had lower first-trimester bHCG concentrations (0.93 MoM vs. 1.11 MoM, p = 0.03). However, none of the correlations in our study translated into a robust prognostic ability for predicting dichotomous outcomes. All areas under the curve achieved a value < 0.7. Conclusions: Low concentrations of PAPP-A and free bHCG subunit in the first trimester may be associated with poorer clinical and biochemical conditions in neonates post-delivery. However, the relationship is weak and has limited predictive capability. Further research evaluating these relationships is necessary for the appropriate stratification of pregnant women into high-risk categories for neonatological complications.
- Open Access
- 23 February 2024
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 25, e943419-e943419-7
Enhanced Diagnostic Capabilities: Ultrasound Imaging of Fetal Alimentary Tract Obstruction with Advanced Imaging Technologies
Enhanced Diagnostic Capabilities: Ultrasound Imaging of Fetal Alimentary Tract Obstruction with Advanced Imaging Technologies - Article abstract #943419
- 23 February 2024
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 25, e943419-e943419-7
Open AccessEnhanced Diagnostic Capabilities: Ultrasound Imaging of Fetal Alimentary Tract Obstruction with Advanced Imaging Technologies
Enhanced Diagnostic Capabilities: Ultrasound Imaging of Fetal Alimentary Tract Obstruction with Advanced Imaging Technologies - Article abstract #943419